Category: | Medical & Pharma, Pharmaceuticals |
---|---|
Organizer: | Magnus Group |
Exhibition center: | Boston |
Hotels search near to Boston
Overview interest facts - International Vaccines Congress 2023
Magnus Group gleefully announces its the “Edition of International Vaccines Congress” (IVC) which is scheduled to take place virtually and can also be attended in-person at Boston, Massachusetts, USA.
The Vaccine congress will run on its unique theme “Synergy to Rehabilitate Innovations in Vaccine Research and Development.”
Whether you're just starting your career or have been in practise for a while, you'll find educational opportunities to help you improve your skills and advance your career. IVC is a well-known forum for bringing science and business together. It congregates premier biotech and pharmaceutical industry specialists, scientists, researchers, vaccinologists, healthcare professionals, academicians, pharmacists, clinicians and decision-makers who are passionate about translating ideas into solutions to address critical global concerns. IVC is the place to be if you have new or original data or research to share. The most recent discoveries and research will be presented and discussed through the plenary talks, keynote speeches, symposiums, oral and poster sessions. The most well-known experts in the field of vaccines will present their findings from the previous year. Joining this hybrid vaccine summit will provide you with a once-in-a-lifetime opportunity to be the first to hear about path breaking research and innovations and keep up to date on current trends in vaccine.
Recommended events
Find airticket to International Vaccines Congress 2023
Recommended events
News
AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan
A month after Novartis made its entry into the paroxysmal nocturnal haemoglobinuria (PNH) field, AstraZeneca’s newest contender Voydeya bolsters the company’s presence...
22 January 2024New material improves treatment of complex bone infections
Researchers in Ireland have combined antimicrobial implants and gene therapies to develop a new surgical solution with the potential to improve the treatment of comple...
29 November 2023Sepsis - as common as cancer, as deadly as a heart attack
In 2016, the research team conducted an initial study in southern Sweden (Skåne) where they revealed that sepsis is much more common than previously believed.
04 September 2023FDA approves first oral treatment for postpartum depression
Following the approval, Biogen plans for the commercial launch Zurzuvae (zuranolone) in Q4 2023.
10 August 2023New blood test finds two thirds of cancers
A new multi-cancer early detection blood test could speed up diagnosis.
16 June 2023EU Proposes Drug Manufacturing Overhaul, Faces Pushback
The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws
04 May 2023